Authors : Wang X; Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University, School of Medicine, Shanghai 200025, China.; Key Laboratory of Protection, Development and Utilization of Medicinal Resources in Liupanshan Area, Ministry of Education, Peptide & Protein Drug Research Center, School of Pharmacy, Ningxia Medical University, Yinchuan 750004, China.

Source: Acta pharmaceutica Sinica. B [Acta Pharm Sin B] 2024 Jun; Vol. 14 (6), pp. 2631-2645. Date of Electronic Publication: 2024 Mar 19.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101600560 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Pharmacokinetic enhancement of oncolytic virus M1 by inhibiting JAK‒STAT pathway.

Authors : Tan J; Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China.; Zhang J

Source: Acta pharmaceutica Sinica. B [Acta Pharm Sin B] 2024 Jun; Vol. 14 (6), pp. 2554-2566. Date of Electronic Publication: 2024 Mar 10.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101600560 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Nanotherapeutics targeting autophagy regulation for improved cancer therapy.

Authors : Liu Y; College of Pharmacy, Nankai University, Tianjin 300350, China.; Wang Y

Source: Acta pharmaceutica Sinica. B [Acta Pharm Sin B] 2024 Jun; Vol. 14 (6), pp. 2447-2474. Date of Electronic Publication: 2024 Mar 18.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101600560 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Precise nano-system-based drug delivery and synergistic therapy against androgen receptor-positive triple-negative breast cancer.

Authors : Gao F; Department of Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.; Wu Y

Source: Acta pharmaceutica Sinica. B [Acta Pharm Sin B] 2024 Jun; Vol. 14 (6), pp. 2685-2697. Date of Electronic Publication: 2024 Mar 14.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101600560 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Erratum: Author correction to 'VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity' [Acta Pharm Sin B 11 (2021) 420-433].

Authors : Shang P; Antibody Engineering Laboratory, School of Life Science & Technology, China Pharmaceutical University, Nanjing 210009, China.; Gao R

Source: Acta pharmaceutica Sinica. B [Acta Pharm Sin B] 2024 Jun; Vol. 14 (6), pp. 2790. Date of Electronic Publication: 2024 Feb 22.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101600560 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

A combined nanotherapeutic approach targeting farnesoid X receptor, ferroptosis, and fibrosis for nonalcoholic steatohepatitis treatment.

Authors : Fu J; The Center for Basic Research and Innovation of Medicine and Pharmacy (MOE), School of Pharmacy, Naval Medical University, Shanghai 200433, China.; Zhang P

Source: Acta pharmaceutica Sinica. B [Acta Pharm Sin B] 2024 May; Vol. 14 (5), pp. 2228-2246. Date of Electronic Publication: 2024 Feb 26.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101600560 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

The inhibitory effect of adenosine on tumor adaptive immunity and intervention strategies.

Authors : Wang L; Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.; Zhang J

Source: Acta pharmaceutica Sinica. B [Acta Pharm Sin B] 2024 May; Vol. 14 (5), pp. 1951-1964. Date of Electronic Publication: 2023 Dec 16.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101600560 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

5 S -Heudelotinone alleviates experimental colitis by shaping the immune system and enhancing the intestinal barrier in a gut microbiota-dependent manner.

Authors : Meng Q; State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin 300353, China.; Guo J

Source: Acta pharmaceutica Sinica. B [Acta Pharm Sin B] 2024 May; Vol. 14 (5), pp. 2153-2176. Date of Electronic Publication: 2024 Feb 29.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101600560 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Transcription factor EHF interacting with coactivator AJUBA aggravates malignancy and acts as a therapeutic target for gastroesophageal adenocarcinoma.

Authors : Peng L; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China.; Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China.

Source: Acta pharmaceutica Sinica. B [Acta Pharm Sin B] 2024 May; Vol. 14 (5), pp. 2119-2136. Date of Electronic Publication: 2024 Mar 04.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101600560 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Emerging non-antibody‒drug conjugates (non-ADCs) therapeutics of toxins for cancer treatment.

Authors : Xu X; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.; Zhang J

Source: Acta pharmaceutica Sinica. B [Acta Pharm Sin B] 2024 Apr; Vol. 14 (4), pp. 1542-1559. Date of Electronic Publication: 2023 Nov 30.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101600560 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي